Covid 19 Research using Clinical Trials (Home Page)
Observational studyWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
Correlated MeSH Terms (1)
|
Name (Synonyms) |
Correlation |
D016638 | Critical Illness NIH | 0.13 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
The study will prospectively collect data from patients with Covid-19 admitted to the
Västerås Intensive Care Unit, Västerås Hospital. Demographic, clinical, radiographic and
laboratory characteristics will be recorded. Analysis of data to identify predictors of
disease severity, mortality and treatment response.
NCT04382417 Covid-19 Critical Illness Other: Observational study
Primary Outcomes
Measure: Demographic characteristics of patients with Covid-19 receiving intensive care Time: Until 30 days after admittance to Intensive Care
Secondary Outcomes
Measure: Survival rate in patients with Covid-19 receiving intensive care Time: 30 days and 6 months after admission to intensive care
Measure: Clinical course characteristics of patients with Covid-19 receiving intensive care Time: Until 30 days after admittance to Intensive Care
Measure: Number of days on mechanical ventilation Time: Until 30 days after admittance to Intensive Care
No related HPO nodes (Using clinical trials)